GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹542 Cr | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹542 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹1,066 Cr |
| Mar2022 | ₹921 Cr |
| Mar2021 | ₹1,218 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹542 Cr | 29.25 | |
| Mar2024 | ₹419 Cr | -60.66 | |
| Mar2023 | ₹1,066 Cr | 15.71 | |
| Mar2022 | ₹921 Cr | -24.36 | |
| Mar2021 | ₹1,218 Cr | - | |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,360.2 Cr | 3.5% | 3% | 40.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3.5% |
3% |
40.1% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses